http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021137858-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07d0dd0404c7bae52ec064e53d61f069 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate | 2020-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219604880b990598ad0550c43be2d7a2 |
| publicationDate | 2021-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021137858-A1 |
| titleOfInvention | Combination formulation containing colchicine for treatment or enhancing the therapy of liver disease |
| abstract | Exemplary embodiment of the present invention relate to a combination formulation for treatment or enhancing the therapy of liver disease, and more specifically, to a pharmaceutical composition for treatment or enhancing the therapy of liver disease which is prepared by combining drugs (biphenyldimethyl dicarboxylate, silymarin, ursodeoxycholic acid, etc.) which are known to have a conventional liver protective effect and colchicine to be administered in a combination formulation or in a combination form. n The composition according to embodiments of the present invention is a pharmaceutical composition for the treatment or enhancing the therapy of liver disease of a liver protective agent containing colchicine, and may be usefully used as a pharmaceutical composition for enhancing the therapy of liver fibrosis, liver cirrhosis, liver cancer or inflammatory liver disease including hepatitis by administering the colchicine in a single-dosage combination formulation or a separate-dosage combination form with the liver protective agent. |
| priorityDate | 2019-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.